Drug design: 4-thiazolidinones applications. Part 2. Pharmacological profiles
HTML

Keywords

Structure-based drug design
5-Ene-4-thiazolidinones
Thiopyrano[2,3-d]thiazoles
biological activity
SAR analysis
Michael acceptors

How to Cite

1.
Lesyk R. Drug design: 4-thiazolidinones applications. Part 2. Pharmacological profiles. JMS [Internet]. 2020Jun.26 [cited 2020Jul.7];89(2):e407. Available from: https://jms.ump.edu.pl/index.php/JMS/article/view/407

Abstract

Following of the chemical diversity of 4-thiazolidinones the in-house library of new heterocycles have been designed and synthesized (more 7000 compounds). Anticancer, antitrypanosomal, antituberculosis and antiviral activity screening led to SAR database formation; lead-compounds identification; design of focused sub-libraries; formation and validation of hypotheses for structure optimization: i) complications of C5 fragment and/or functionalization of N3 position; ii) creation of the hybrid molecules; iii) fixation of 5-ene-4-thiazolidinones in fused heterocycles via annulation (thiopyrano[2,3-d]thiazoles were found as a cyclic isosteric mimetics of 5-ene-4-thiazolidinones); iv) the leukemia panel was detected to be the most sensitive among all cancer cell lines. Following the in silico and pharmacological data for the investigation of molecular mechanism of anticancer effect the argument in favor of the apoptotic related and mild prooxidant actions for active compounds have been found.

https://doi.org/10.20883/medical.e407
HTML

References

Lesyk RB, Zimenkovsky BS, Kaminskyy DV, Kryshchyshyn AP, Havrylyuk DYa, Atamanyuk DV, et al. Thiazolidinone motif in anticancer drug discovery. Experience of DH LNMU medicinal chemistry scientific group. Biopolym Cell. 2011; 27: 107–117.
Devinyak O, Zimenkovsky B, Lesyk R. Biologically Active 4-Thiazolidinones: a Review of QSAR Studies and QSAR Modeling of Antitumor Activity. Curr Top Med Chem. 2012; 12(14): 2763-2784.
Devinyak O, Havrylyuk D, Zimenkovsky B, Lesyk R. Computational Search for Possible Mechanisms of 4-Thiazolidinones Anticancer Activity: The Power of Visualization. Mol Inform. 2014; 33(3): 216-229.
Lesyk R, Vladzimirska O, Zimenkovsky B, Golota S, Nektegayev I, Cherpak O, et al. Synthesis and antiinflammatory activity of novel 3-(2,3-dimethyl-1-phenyl-4-pyrazon-5-yl)-4-thiazolidones. Boll Chim Pharm. 2002; 141(3): 197-201.
Lesyk R, Vladzimirska O, Zimenkovsky B, Horishny V, Nektegayev I, Solyanyk V, Vovk O. New thiazolidones-4 with pyrazolone-5 substituent as the potential NSAIDs. Boll Chim Pharm. 1998; 137(6): 210-217.
Zimenkovskii BS, Kutsyk RV, Lesyk RB, Matyichuk VS, Obushak ND, Klyufinska TI. Synthesis and antimicrobial activity of 2,4-dioxothiazolidine-5-acetic acid amides. Pharm Chem J. 2006; 40(6): 303-306.
Lesyk RB, Pinyazhko OR, Myronenko SI, Nektegayev IO. 5-(3-Nitrobenzylidene)-2-(thiazol-2-ylimino)-4-thiazolidinone exhibiting anticonvulsant effect. Patent UA 105330. Disclosure 12.10.2015. Published 10.03.2016. Bull. №5 (in Ukrainian).
Nektegayev I, Lesyk R. 3-Oxyaryl-2-thionethiazolidones-4 and their choleretic activity. Sci Pharm. 1999; 67: 227-230.
Boyd MR, Paull KD. Some practical considerations and applications of the National Cancer Institute in vitro anticancer drug discovery screen. Drug Dev Res. 1995; 34: 91-109.
Shoemaker RH. The NCI60 human tumor cell line anticancer drug screen. Nat Rev Cancer 2006; 6: 813-823.
Paull KD, Shoemaker RH, Hodes L, Monks A, Scudiero DA, Rubinstein L, et al. Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm. J. Natl. Cancer Inst. 1989; 81: 1088–1092.
Havrylyuk D, Mosula L, Zimenkovsky B, Vasylenko O, Gzella A, Lesyk R. Synthesis and anticancer activity evaluation of 4-thiazolidinones containing benzothiazole moiety. Eur J Med Chem. 2010; 45(11): 5012-5021.
Kaminskyy D, Hartog GJM, Wojtyra M, Lelyukh M, Gzella A, Bast A, Lesyk R. Antifibrotic and anticancer action of 5-ene amino/iminothiazolidinones. Eur J Med Chem. 2016; 112: 180-195.
Senkiv J, Finiuk N, Kaminskyy D, Havrylyuk D, Wojtyra M, Kril I, et al. 5-Ene-4-thiazolidinones induce apoptosis in mammalian leukemia cells. Eur J Med Chem. 2016; 117: 33-46.
Kaminskyy D, Khyluk D, Vasylenko O, Zaprutko L, Lesyk R. A facile synthesis and anticancer activity evaluation of spiro[thiazolidinone-isatin] conjugates. Sci Pharm. 2011; 4: 763-777.
Havrylyuk D, Zimenkovsky B, Vasylenko O, Gzella A, Lesyk R. Synthesis of New 4-Thiazolidinone-, Pyrazoline-, and Isatin-Based Conjugates with Promising Antitumor Activity. J Med Chem. 2012; 55: 8630-8641.
Kaminskyy D, Zimenkovsky B, Lesyk R. Synthesis and in vitro anticancer activity of 2,4-azolidinedione-acetic acids derivatives. Eur J Med Chem. 2009; 44(9): 3627-3636.
Havrylyuk D, Zimenkovsky B, Lesyk R. Synthesis and Anticancer Activity of Novel Nonfused Bicyclic Thiazolidinone Derivatives. Phosphorus Sulfur Silicon Relat Elem. 2009; 184: 638-650.
Subtelna I, Atamanyuk D, Szymańska E, Kieć-Kononowicz K, Zimenkovsky B, Vasylenko O, et al. Synthesis of 5-arylidene-2-amino-4-azolones and evaluation of their anticancer activity. Bioorg Med Chem. 2010; 18(14): 5089-5101.
Havrylyuk D, Kovach N, Zimenkovsky B, Vasylenko O, Lesyk R. Sуnthesis and Anticancer Activity of Isatin-Based Pyrazolines and Thiazolidines Conjugates. Arch Pharm Chem Life Sci. 2011; 344(8): 514–522.
Avdieiev S, Gera L, Havrylyuk D, Hodges RS, Lesyk R, Ribrag V, et al. Bradykinin antagonists and thiazolidinone derivatives as new potential anti-cancer compounds. Bioorg Med Chem. 2014; 22: 3815-3823.
Kaminskyy D, Subtel’na I, Zimenkovsky B, Karpenko O, Gzella A, Lesyk R. Synthesis and evaluation of anticancer activity of 5-ylidene-4-aminothiazol-2(5H)-one derivatives. Med Chemi. 2015; 11(6): 517-530.
Szychowski KA, Leja ML, Kaminskyy DV, Binduga UE, Pinyazhko OR, Lesyk RB, Gminski J. Study of novel anticancer 4-thiazolidinone derivatives. Chem-Biol Interact. 2017; 262: 46-56.
Szychowski KA, Leja ML, Kaminskyy DV, Kryshchyshyn AP, Binduga UE, Pinyazhko OR, et al. Anticancer properties of 4-thiazolidinone derivatives depend on peroxisome proliferator-activated receptor gamma (PPARγ). Eur J Med Chem. 2017; 141: 162-168.
Szychowski KA, Kaminskyy DV, Leja ML, Kryshchyshyn AP, Lesyk RB, Tobiasz J, et al. Anticancer properties of 5Z-(4-fluorobenzylidene)-2-(4-hydroxyphenylamino)-thiazol-4-one. Sci Rep. 2019; 9: 1-16.
Lozynskyi A, Golota S, Zimenkovsky B, Atamanyuk D, Gzella A, Lesyk R. Synthesis, anticancer and antiviral activities of novel thiopyrano[2,3-d]thiazole-6-carbaldehydes. Phosphorus Sulfur Silicon Relat Elem. 2016; 191(9): 1245-1249.
Kryshchyshyn AP, Atamanyuk DV, Kaminskyy DV, Grellier P, Lesyk RB. Investigation of anticancer and anti-parasitic activity of thiopyrano[2,3-d]thiazoles bearing norbornane moiety. Biopolym Cell. 2017; 33(3): 183-205.
Atamanyuk D, Zimenkovsky B, Lesyk R. Synthesis and anticancer activity of novel thiopyrano[2.3-d]thiazole-based compounds containing norbornane moiety. J Sulfur Chem. 2008; 29(2): 151-162.
Atamanyuk D, Zimenkovsky B, Atamanyuk V, Nektegayev I, Lesyk R. Synthesis and Biological Activity of New Thiopyrano[2,3-d]thiazoles Containing a Naphthoquinone Moiety. Sci Pharm. 2013; 81(2): 423-436.
Zelisko NI, Finiuk NS, Shvets VM, Medvid YO, Stoika RS, Lesyk RB. Screening of spiro-substituted thiopyrano[2,3-d]thiazoles for their cytotoxic action on tumor cells. Biopolym Cell. 2017; 33(4): 282-290.
Zimenkovsky BS, Devinyak OT, Havrylyuk DYa, Lesyk RB. Analysis of antitumor activity of 4-thiazolidinone derivatives and their classification by probable mechanisms of action using mathematical statistics. Journal of Organic and Pharmaceutical Chemistry. 2011; 9(3): 64-71 (in Ukrainian).
Zimenkovsky BS, Devinyak OT, Lesyk RB. Study of the structure-antitumor activity of 4-thiazolidinone derivatives using regression analysis and classification modeling. Journal of Organic and Pharmaceutical Chemistry. 2012; 10(2): 43-49 (in Ukrainian).
Devinyak OT, Lesyk RB. Investigation of the relationship between the structure of 4-thiazolidinones and their antitumor activity by multidimensional adaptive regression splines. Journal of Organic and Pharmaceutical Chemistry. 2013; 11(3): 62-67 (in Ukrainian).
Senkiv J, Finiuk N, Kaminskyy D, Havrylyuk D, Wojtyra M, Kril I, et al. 5-Ene-4-thiazolidinones induce apoptosis in mammalian leukemia cells. Eur J Med Chem. 2016; 117: 33-46.
Chumak VV, Fil’ MR, Panchuk RR, Zimenkovsky BS, Havrylyuk DYa, Lesyk RB, Stoika RS. Study of antineoplastic action of novel isomeric derivatives of 4-thiazolidinone. Ukr Biochem J. 2014; 86(6): 96-105.
Коbylinska LI, Boiko NM, Panchuk RR, Grytsyna II, Klyuchivska OYu, Biletska LP, et al. Putative anticancer potential of novel 4-thiazolidinone derivatives: cytotoxicity toward rat C6 glioma in vitro and correlation of general toxicity with the balance of free radical oxidation in rats. Croat Med J. 2016; 57(2): 151-163.
Havrylyuk DYa, Zimenkovsky BS, Lesyk RB, Stoika RS, Lutsyk MD, Panchuk RR. 5-[2-Chloro-3-(4-nitrophenyl)-allylidene]-4-(3,5-diaryl-4,5-dihydropyrazol-1-yl)-5H-thiazol-2-ones exhibiting antitumor activity in vitro and in vivo, and their solubilization method. Patent UA 109177. Disclosure 21.08.2013. Published 27.07.2015. Bull. №14 (in Ukrainian).
Zimenkovsky BS, Devinyak OT, Lesyk RB. Modeling of a possible pharmacophore group of 4-thiazolidinones with antitumor activity. Journal of Organic and Pharmaceutical Chemistry. 2012; 10(4): 76-82 (in Ukrainian).
Zimenkovsky BS, Lesyk RB, Devinyak OT, Havrylyuk DYa. Method for antitumor activity predicting of 4-thiazolidinone derivatives. Patent UA 80435. Disclosure 18.12.2012. Published 27.05.2013. Bull. №10 (in Ukrainian).
Havrylyuk DYa, Zimenkovsky BS, Vasylenko OM, Lesyk RB. Synthesis and study of antiviral activity of thiazolone derivatives with pyrazoline moiety in molecules. Journal of Organic and Pharmaceutical Chemistry. 2009; 7(1): 42-47 (in Ukrainian).
Havrylyuk D, Zimenkovsky B, Vasylenko O, Lesyk R. Synthesis and Anticancer and Antiviral Activities of New 2-Pyrazoline-Substituted 4-Thiazolidinones. J Heterocycl Chem. 2013; 50(S1): E55-E62.
Zelisko NI, Demchuk IL, Lesyk RB. New thiopyrano[2,3-d]thiazoles as potential antiviral agents. Ukr Biochem J. 2016; 88 Suppl.: 105-112.
Havrylyuk D, Zimenkovsky B, Vasylenko O, Day CW, Smee DF, Grellier P, Lesyk R. Synthesis and biological activity evaluation of 5-pyrazoline substituted 4-thiazolidinones. Eur J Med Chem. 2013; 66: 228-237.
Wojtyra MN, Lesyk RB, Zimenkovsky BS, Grellier P. (Z)-(5-[5-(3,5-diaryl-4,5-dihydropyrazol-1-yl-methylidene)-3-(pyridine-3-yl)-2-thioxothiazolidin-4-ones exhibiting antitrypanosomal action. Patent UA 119822. Disclosure 18.04.2017. Published 10.10.2017. Bull. №19 (in Ukrainian).
Holota S, Kryshchyshyn A, Derkach H, Trufina Y, Demchuk I, Gzella A, et al. Synthesis of 5-enamine-4-thiazolidinone derivatives with trypanocidal and anticancer activity. Bioorg Chem. 2019; 86: 126-136.
Kryshchyshyn A, Kaminskyy D, Karpenko O, Gzella A, Grellier P, Lesyk R. Thiazolidinone/thiazole based hybrids – New class of antitrypanosomal agents. Eur J Med Chem. 2019; 174: 292-308.
Zelisko N, Karpenko O, Muzychenko V, Gzella A, Grellier P, Lesyk R. trans-Aconitic acid-based hetero-Diels-Alder reaction in the synthesis of thiopyrano[2,3-d][1,3]thiazole derivatives. Tetrahedron Lett. 2017; 58(18): 1751-1754.
Zelisko N, Atamanyuk D, Vasylenko O, Grellier P, Lesyk R. Synthesis and antitrypanosomal activity of new 6,6,7-trisubstituted thiopyrano[2,3-d][1,3]thiazoles. Bioorg Med Chem Lett. 2012; 22(23): 7071-7074.
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2020 Array

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...